# US 2012/0253048 A1 · Ribonucleotide reductase inhibitors and methods of use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0253048 A1
- Document ID: US20120253048A1
- Status: Published application
- Kind: A1
- Application number: 13/364,263
- Filed: 2012-02-01
- Published: 2012-10-04
- Earliest claimed: 2008-04-08
- Assignees: City of Hope
- Inventors: Yun Yen; David Horne; Christopher Lincoln
- Web page: https://patentgrep.com/patent/US20120253048A1

## CPC

- C07D 277/46: by carboxylic acids, or sulfur or nitrogen analogues thereof
- C07D 417/12: linked by a chain containing hetero atoms as chain links
- C12N 9/99: Enzyme inactivation by chemical treatment
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Provided herein are novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2 and interfering with the activity of the RRM1/RRM2 holoenzyme, as well as methods of synthesizing these novel compounds. The compounds may be used to inhibit RR activity and to treat various conditions associated with RRM2 expression, such as for example certain cancer types, mitochondrial diseases, or degenerative diseases.

## Claims

### Claim 1

A method of synthesizing a compound having the structure:
comprising the steps:
(a) converting veratrole to 1-(3,4-dimethoxyphenyl)-2-phenylethanone;
(b) converting 1-(3,4-dimethoxyphenyl)-2-phenylethanone to 4-(3,4-dimethoxyphenyl)-5-phenylthiazol-2-amine;
(c) converting 4-(3,4-dimethoxyphenyl)-5-phenylthiazol-2-amine to N-(4-(3,4-dimethoxyphenyl)-5-phenylthiazol-2-yl)-3,4-dimethoxybenzamide; and
(d) converting N-(4-(3,4-dimethoxyphenyl)-5-phenylthiazol-2-yl)-3,4-dimethoxybenzamide to

### Claim 2 (depends on 1)

The method of claim 1, wherein synthesis occurs via the following pathway:
